Sonic Healthcare Limited
ASX: SHL
Specialised testing demand and strategic global acquisitions drove a uplift.
(Source: TradingView) 3-Month Performance Profile of SHL on a DTF compared to S&P/ASX 200 (XJO).
FY25’s results were driven by a noticeable rise in demand for specialised diagnostics, helped by fresh contract additions. These included the Hertfordshire & West Essex NHS deal a
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
